SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-012191
Filing Date
2023-04-07
Accepted
2023-04-07 16:02:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A sndx-2023-04-05-defa_14a.htm DEFA14A 21736
2 GRAPHIC img263986506_0.jpg GRAPHIC 1207136
3 GRAPHIC img263986506_1.jpg GRAPHIC 289163
  Complete submission text file 0000950170-23-012191.txt   2083617
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37708 | Film No.: 23808797
SIC: 2834 Pharmaceutical Preparations